AstraZeneca PLC (AZN)
NASDAQ: AZN · Real-Time Price · USD
74.48
-0.11 (-0.15%)
At close: Aug 5, 2025, 4:00 PM
74.62
+0.14 (0.19%)
Pre-market: Aug 6, 2025, 9:01 AM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Oncology | 20.28B | Log In | Log In | Log In | Log In | Upgrade |
Oncology Growth | 21.07% | Log In | Log In | Log In | Log In | Upgrade |
BioPharmaceuticals: CVRM | 12.45B | Log In | Log In | Log In | Log In | Upgrade |
BioPharmaceuticals: CVRM Growth | 10.83% | Log In | Log In | Log In | Log In | Upgrade |
BioPharmaceuticals: R&I | 7.42B | Log In | Log In | Log In | Log In | Upgrade |
BioPharmaceuticals: R&I Growth | 21.18% | Log In | Log In | Log In | Log In | Upgrade |
Other Medicines | 1.07B | Log In | Log In | Log In | Log In | Upgrade |
Other Medicines Growth | -8.28% | Log In | Log In | Log In | Log In | Upgrade |
COVID-19 | - | Log In | Log In | Log In | Log In | Upgrade |
COVID-19 Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Collaboration | 3.14B | Log In | Log In | Log In | Log In | Upgrade |
Collaboration Growth | 3.05% | Log In | Log In | Log In | Log In | Upgrade |
BioPharmaceuticals V&I | 1.06B | Log In | Log In | Log In | Log In | Upgrade |
BioPharmaceuticals V&I Growth | 28.00% | Log In | Log In | Log In | Log In | Upgrade |
Rare Disease | 8.67B | Log In | Log In | Log In | Log In | Upgrade |
Rare Disease Growth | 7.00% | Log In | Log In | Log In | Log In | Upgrade |
Capex by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
UK Assets Acquired | 582.00M | Log In | Log In | Log In | Log In | Upgrade |
UK Assets Acquired Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Rest of Europe Assets Acquired | 2.23B | Log In | Log In | Log In | Log In | Upgrade |
Rest of Europe Assets Acquired Growth | - | Log In | Log In | Log In | Log In | Upgrade |
The Americas Assets Acquired | 3.93B | Log In | Log In | Log In | Log In | Upgrade |
The Americas Assets Acquired Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Asia, Africa & Australasia Assets Acquired | 1.39B | Log In | Log In | Log In | Log In | Upgrade |
Asia, Africa & Australasia Assets Acquired Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
UK Operating Profit | 2.68B | Log In | Log In | Log In | Log In | Upgrade |
UK Operating Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Rest of Europe Operating Profit | 5.92B | Log In | Log In | Log In | Log In | Upgrade |
Rest of Europe Operating Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
The Americas Operating Profit | 423.00M | Log In | Log In | Log In | Log In | Upgrade |
The Americas Operating Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Asia, Africa & Australasia Operating Profit | 976.00M | Log In | Log In | Log In | Log In | Upgrade |
Asia, Africa & Australasia Operating Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
UK Revenue | 4.74B | Log In | Log In | Log In | Log In | Upgrade |
UK Revenue Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Rest of Europe | 11.70B | Log In | Log In | Log In | Log In | Upgrade |
Rest of Europe Growth | - | Log In | Log In | Log In | Log In | Upgrade |
The Americas | 24.99B | Log In | Log In | Log In | Log In | Upgrade |
The Americas Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Asia, Africa & Australasia | 12.64B | Log In | Log In | Log In | Log In | Upgrade |
Asia, Africa & Australasia Growth | - | Log In | Log In | Log In | Log In | Upgrade |